Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Calvert

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Cancer Research|October 15, 1991
ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical studyA L Jackman, G A Taylor, W Gibson, et al.
Cancer Treatment Reports|January 1, 1981
Methotrexate with thymidine, inosine, and allopurinol rescue: a phase I clinical studyP J Dady, G A Taylor, J F Muindi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalationB J Foster, D R Newell, M A Graham, et al.
British Journal of Cancer|December 1, 1987
Tumour necrosis factor in man: clinical and biological observationsP Selby, S Hobbs, C Viner, et al.
Oncology|January 1, 1978
Improved results in combination chemotherapy of head and neck cancer using a kinetically-based approach: a randomised study with and without adriamycinL A Price, B T Hill, A H Calvert, et al.
Human Pathology|May 23, 2008
Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancerS J Wilkinson, A Kucukmetin, P Cross, et al.
Journal of Medicinal Chemistry|April 1, 1986
Quinazoline antifolates inhibiting thymidylate synthase: benzoyl ring modificationsT R Jones, M J Smithers, M A Taylor, et al.
Seminars in Oncology|December 1, 1996
Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee studyD Porter, A Boddy, H Thomas, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatinD R Newell, Z H Siddik, L A Gumbrell, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1996
Bioequivalence assessment of etoposide phosphate and etoposide using pharmacodynamic and traditional pharmacokinetic parametersV Mummaneni, S Kaul, L N Igwemezie, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Cancer Research|October 15, 1991
ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical studyA L Jackman, G A Taylor, W Gibson, et al.
Cancer Treatment Reports|January 1, 1981
Methotrexate with thymidine, inosine, and allopurinol rescue: a phase I clinical studyP J Dady, G A Taylor, J F Muindi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I trial of the anthrapyrazole CI-941: prospective evaluation of a pharmacokinetically guided dose-escalationB J Foster, D R Newell, M A Graham, et al.
British Journal of Cancer|December 1, 1987
Tumour necrosis factor in man: clinical and biological observationsP Selby, S Hobbs, C Viner, et al.
Oncology|January 1, 1978
Improved results in combination chemotherapy of head and neck cancer using a kinetically-based approach: a randomised study with and without adriamycinL A Price, B T Hill, A H Calvert, et al.
Human Pathology|May 23, 2008
Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancerS J Wilkinson, A Kucukmetin, P Cross, et al.
Journal of Medicinal Chemistry|April 1, 1986
Quinazoline antifolates inhibiting thymidylate synthase: benzoyl ring modificationsT R Jones, M J Smithers, M A Taylor, et al.
Seminars in Oncology|December 1, 1996
Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee studyD Porter, A Boddy, H Thomas, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatinD R Newell, Z H Siddik, L A Gumbrell, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1996
Bioequivalence assessment of etoposide phosphate and etoposide using pharmacodynamic and traditional pharmacokinetic parametersV Mummaneni, S Kaul, L N Igwemezie, et al.
Pageof 15